CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating Activities
Net income	$ 8,693	$ 11,883
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
Depreciation expense	55,825	58,085
Amortization expense	41,665	39,900
Amortization of deferred financing fees	3,102	3,350
Debt extinguishment charges	3,931
Deferred income taxes	(4,496)	(5,407)
Stock compensation	26,044	981
Unrealized foreign currency loss (gain)	2,818	(2,865)
Other	1,837	420
Change in assets and liabilities:
Accounts receivable	(11,887)	(12,962)
Inventories	5,231	13,336
Prepaid expenses and other current assets	355	(4,136)
Other assets	(7,201)	4,813
Accounts payable	(13,495)	(39,495)
Payroll and benefits	(13,110)	(2,111)
Other current liabilities	(10,010)	6,996
Income taxes payable	2,205	6,941
Other long-term liabilities	(2,590)	(14,508)
Net cash and cash equivalents provided by operating activities	88,917	65,221
Investing Activities
Additions to property, plant and equipment	(36,719)	(37,678)
Additions to intangible assets	(265)	(176)
Proceeds from sale of assets	2,616	5,962
Acquisitions of businesses, net of cash acquired	(10,685)	(137,783)
Net cash and cash equivalents used in investing activities	(45,053)	(169,675)
Financing Activities
Proceeds from initial public offering	186,424
Payments of offering costs	(7,024)
Proceeds from issuance of long-term debt		136,845
Proceeds from short-term borrowings	44,502	148,849
Payments on short-term borrowings	(43,755)	(151,394)
Payments on long-term debt	(235,627)	(12,592)
Deferred financing costs		(4,959)
Net cash and cash equivalents (used in) provided by financing activities	(55,480)	116,749
Effect of exchange rate changes on cash and cash equivalents	2,492	(673)
(Decrease) increase in cash and cash equivalents	(9,124)	11,622
Cash and cash equivalents-beginning	55,675	27,533
Cash and cash equivalents-ending	$ 46,551	$ 39,155